Atopic dermatitis as a side effect of anti-tumor necrosis factor-alpha therapy.
Mangge
Harald
H
Clinical Institute of Medical and Chemical Laboratory Diagnosis, University of Graz, A-8036 Graz, Austria. harald.mangge@uni-graz.at
Gindl
Sonja
S
Kenzian
Harald
H
Schauenstein
Konrad
K
D001171:Arthritis, Juvenile / Q000188:drug therapy*; D002648:Child; D003876:Dermatitis, Atopic / Q000139:chemically induced* / Q000473:pathology; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects*; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept